Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone

American Journal of Cardiology

Volumn 94, Issue 10, 2004, Pages 1329-1332

  Nanas, John N ^a,b   Papazoglou, Panagiotis P ^a   Terrovitis, John V ^a   Kanakakis, John ^a   Dalianis, Argirios ^a   Tsolakis, Elias ^a   Tsagalou, Eleftheria P ^a   Agrios, Nikolaos ^a   Christodoulou, Kostantinos ^a   Anastasiou Nana, Maria I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Greece ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; LEVOSIMENDAN; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INDEX; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CARDIAC OUTPUT; CARDIOTONIC AGENTS; DIURETICS; DOBUTAMINE; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYDRAZONES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; PYRIDAZINES;

EID: 7944221097     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.07.128     Document Type: Article

References (9)

1. J.M. Aranda Jr, R.S. Schofield, D.F. Pauly, T.S. Cleeton, T.C. Walker, V.S. Monroe Jr, D. Leach, L.M. Lopez, J.A. Hill Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial Am Heart J 145 2003 324 329
2. H. Haikala, J. Kaivola, E. Nissinen, P. Wall, J. Levijoki, I.B. Linden Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan J Mol Cell Cardiol 27 1995 1859 1866
3. 2+ sensitizer, levosimendan, to recombinant human cardiac troponin C A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study J Biol Chem 269 1994 2584 2590
4. 2+ channels Biophys J 79 2000 2547 2556
5. D.M. Kaye, A.M. Dart, G.L. Jennings, M.D. Esler Antiadrenergic effect of chronic amiodarone therapy in human heart failure J Am Coll Cardiol 33 1999 1553 1559
6. T. Toyama, H. Hoshizaki, R. Seki, N. Isobe, H. Adachi, S. Naito, S. Oshima, K. Taniguchi Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy J Nucl Cardiol 11 2004 134 141
7. J.N. Nanas, D.A. Kontoyannis, G.P. Alexopoulos, M.I. Anastasiou-Nana, E.P. Tsagalou, S.F. Stamatelopoulos, S.D. Moulopoulos Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure Chest 119 2001 1173 1178
8. J.N. Nanas, E.P. Tsagalou, J. Kanakakis, S.N. Nanas, J. Terrovitis, Th Moon, M.I. Anastasiou-Nana Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure A randomized double-blind study Chest 125 2004 1198 1204
9. D.P. Figgitt, P.S. Gillies, K.L. Goa Levosimendan Drugs 61 2001 613 627